Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

481 ARTÍCULOS , VIENDO DEL 181 AL 195

What's the cut-point?: a systematic investigation of tau PET thresholding methods

Weigand AJ, Maass A, Eglit GL, Bondi MW.

Alzheimers Res Ther. 2022 Apr 5;14(1):49. doi: 10.1186/s13195-022-00986-w.

Quantification of amyloid PET for future clinical use: a state-of-the-art review

Pemberton HG, Collij LE, Heeman F, Bollack A, Shekari M, Salvadó G, Alves IL, Garcia DV, Battle M, Buckley C, Stephens AW, Bullich S, Garibotto V, Barkhof F, Gispert JD, Farrar G; AMYPAD consortium.

Eur J Nucl Med Mol Imaging. 2022 Aug;49(10):3508-3528. doi: 10.1007/s00259-022-05784-y. Epub 2022 Apr 7.

Late-onset epilepsy and the risk of dementia: a systematic review and meta-analysis

Huang L, Fu C, Li J, Peng S.

Aging Clin Exp Res. 2022 Aug;34(8):1771-1779. doi: 10.1007/s40520-022-02118-8. Epub 2022 Apr 15.

Cross-Cultural Longitudinal Study on Cognitive Decline (CLoCODE) for Subjective Cognitive Decline in China and Germany: A Protocol for Study Design

Sheng C, Yang K, He B, Li T, Wang X, Du W, Hu X, Jiang J, Jiang X, Jessen F, Han Y.

J Alzheimers Dis. 2022;87(3):1319-1333. doi: 10.3233/JAD-215452.

Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer's disease

Assunção SS, Sperling RA, Ritchie C, Kerwin DR, Aisen PS, Lansdall C, Atri A, Cummings J.

Alzheimers Res Ther. 2022 Apr 19;14(1):54. doi: 10.1186/s13195-022-00984-y.

Mechanisms Involved in Epileptogenesis in Alzheimer's Disease and Their Therapeutic Implications

Altuna M, Olmedo-Saura G, Carmona-Iragui M, Fortea J.

Int J Mol Sci. 2022 Apr 13;23(8):4307. doi: 10.3390/ijms23084307.

Brain Photobiomodulation Improves Sleep Quality in Subjective Cognitive Decline: A Randomized, Sham-Controlled Study

Zhao X, Du W, Jiang J, Han Y.

J Alzheimers Dis. 2022;87(4):1581-1589. doi: 10.3233/JAD-215715.

Diagnostic performance of hippocampal volumetry in Alzheimer's disease or mild cognitive impairment: a meta-analysis

Park HY, Suh CH, Heo H, Shim WH, Kim SJ.

Eur Radiol. 2022 Oct;32(10):6979-6991. doi: 10.1007/s00330-022-08838-9. Epub 2022 May 4.

Association Between Mild Neurocognitive Disorder Due to Alzheimer's Disease and Possible Attention-deficit/Hyperactivity Disorder: A Case Report

Carrillo P, Rey R, Padovan C, Herrmann M, Dorey JM.

J Psychiatr Pract. 2022 May 1;28(3):251-258. doi: 10.1097/PRA.0000000000000627.

Reflected image processing abnormalities in dementia - a case series and review

Issac TG, Mukku SSR, Mangalore S, Sinha P, Sivakumar PT.

Neurocase. 2022 Apr;28(2):258-262. doi: 10.1080/13554794.2022.2072227. Epub 2022 May 8.

Plasma MMP-9 Levels as the Future Risk of Conversion to Dementia in ApoE4-Positive MCI Patients: Investigation Based on the Alzheimer's Disease Neuroimaging Initiative Database

Abe K, Chiba Y, Ide K, Yoshimi A, Asami T, Suda A, Odawara T, Hishimoto A.

J Prev Alzheimers Dis. 2022;9(2):331-337. doi: 10.14283/jpad.2022.19.

Early diagnosis of Alzheimer's disease based on deep learning: A systematic review

Fathi S, Ahmadi M, Dehnad A.

Comput Biol Med. 2022 Jul;146:105634. doi: 10.1016/j.compbiomed.2022.105634. Epub 2022 May 17.

Spatial navigation in older adults with mild cognitive impairment and dementia: A systematic review and meta-analysis

Plácido J, de Almeida CAB, Ferreira JV, de Oliveira Silva F, Monteiro-Junior RS, Tangen GG, Laks J, Deslandes AC.

Exp Gerontol. 2022 Aug;165:111852. doi: 10.1016/j.exger.2022.111852. Epub 2022 May 27.

Investigating the relationship between mild traumatic brain injury and Alzheimer's disease and related dementias: a systematic review

Clark E, Faruque S, Mutebi C, Nagirimadugu NV, Kim A, Mahendran M, Sullo E, Morey R, Turner RW 2nd.

J Neurol. 2022 Sep;269(9):4635-4645. doi: 10.1007/s00415-022-11186-9. Epub 2022 Jun 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias